Detalles de la búsqueda
1.
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial.
Ann Hematol
; 102(12): 3383-3399, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37792065
2.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Int J Cancer
; 148(6): 1478-1488, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33038277
3.
Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study).
Eur J Haematol
; 101(6): 766-773, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30091166
4.
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
Haematologica
; 94(3): 414-8, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19252176
5.
Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia.
Oncol Rep
; 10(4): 915-20, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12792745
Resultados
1 -
5
de 5
1
Próxima >
>>